Evidence map›Paper›PMID 42031762›Full record

ArticleNature communications2026

Novel CuCLIP-seq for in situ covalently captured protein-binding RNAs.

Xing Wang, Meng-Ke Wang, Bo-Fei Yao, Chun-Chun Gao, Han-Fei Jin, Yu-Sheng Chen, Er-Zhong Wu, Ang Li, Ya-Jing Hao, Yong-Liang Zhao and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xing Wang *China National Center for Bioinformation, Beijing, China.
Meng-Ke Wang *China National Center for Bioinformation, Beijing, China. wangmengke2018zd@big.ac.cn.
Bo-Fei Yao *China National Center for Bioinformation, Beijing, China.
Chun-Chun Gao *China National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0002-5591-1034
Han-Fei JinChina National Center for Bioinformation, Beijing, China.
Yu-Sheng ChenChina National Center for Bioinformation, Beijing, China.
Er-Zhong WuChina National Center for Bioinformation, Beijing, China.
Ang LiShandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences and Qilu Hospital (Qingdao), Shandong University, Qingdao, China.ORCID http://orcid.org/0009-0005-3551-1219
Ya-Jing HaoChina National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0003-1384-4176
Yong-Liang ZhaoChina National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0003-0121-1312
Yun-Gui YangChina National Center for Bioinformation, Beijing, China. ygyang@big.ac.cn.ORCID http://orcid.org/0000-0002-2821-8541
Ying YangChina National Center for Bioinformation, Beijing, China. yingyang@big.ac.cn.ORCID http://orcid.org/0000-0002-8104-5985

Funding

CAS | Beijing Institute of Genomics, Chinese Academy of Sciences (Beijing Institute of Genomics) YSBR-073National Natural Science Foundation of China (National Science Foundation of China) 32030058Youth Innovation Promotion Association of the Chinese Academy of Sciences (Youth Innovation Promotion Association CAS) Y2022040
6 · The paper itself

Abstract

RNA binding proteins (RBPs) are multi-faceted proteins that interact with transcripts in various RNA driven processes and functions. However, in situ covalent capture techniques for screening authentic RNA substrates of RBPs remain challenging in terms of reproducibility, specificity, and sensitivity. Here, we developed CuCLIP-seq (CuAAC-Crosslinking and Immunoprecipitation Sequencing), an alternative in situ covalent capture sequencing method which utilizes CuAAC reaction to crosslink RBP-RNA between azido groups of RBPs and ethynyl groups of RNA molecules, followed by streptavidin-mediated enrichment of RNA substrates and high-throughput sequencing. We demonstrate the reliability of CuCLIP-seq by identifying substrate RNAs of several RBPs, including PTBP1, ADAR2, SRSF2, HNRNPA1, and PINX1, especially for capturing low-abundance targets. Additionally, this approach is authenticated by specifically resolving the alternative splicing transcripts targeted by PTBP1 and RNA targets by PINX1. Thus, this technique offers a sensitive and specific approach for detecting RBP substrates with high reproducibility, potential scalability, and wide applicability.

Indexed as

High-Throughput Nucleotide SequencingRNARNA-Binding ProteinsSequence Analysis, RNAAdenosine DeaminaseAlternative SplicingAnimalsCross-Linking ReagentsHeterogeneous Nuclear Ribonucleoprotein A1Heterogeneous-Nuclear RibonucleoproteinsHumansImmunoprecipitationPolypyrimidine Tract-Binding ProteinReproducibility of ResultsSerine-Arginine Splicing FactorsAdenosine DeaminaseCross-Linking ReagentsHeterogeneous Nuclear Ribonucleoprotein A1Heterogeneous-Nuclear RibonucleoproteinshnRNPA1 protein, humanPolypyrimidine Tract-Binding ProteinPTBP1 protein, humanRNARNA-Binding ProteinsSerine-Arginine Splicing Factors

Identifiers

PMID42031762
PMCPMC13315716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.